Table of Contents
Table 5-9: Cass
Table 5-11: Clay
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 238 | 534.6 | 1,329 | 621.2 | 103 | 254.5 | 586 | 289.7 |
| Esophagus | * | # | 11 | 5.0** | 5 | 11.1** | 13 | 6.3** |
| Stomach | 6 | 16.1** | 27 | 13.5 | * | # | 11 | 5.6** |
| Colon excluding Rectum | 21 | 46.7 | 103 | 50.1 | 7 | 16.9** | 57 | 28.5 |
| Rectum and Rectosigmoid Junction | 11 | 24.0** | 41 | 19.2 | * | # | 8 | 4.0** |
| Liver | * | # | 12 | 5.1** | * | # | 4 | # |
| Pancreas | 7 | 16.0** | 25 | 11.7 | 5 | 12.7** | 22 | 10.6 |
| Lung and Bronchus | 48 | 109.5 | 271 | 130.3 | 44 | 105.8 | 238 | 116.4 |
| Melanoma of the Skin | 9 | 19.9** | 41 | 19.2 | * | # | 6 | 2.3** |
| Prostate | 48 | 104.6 | 371 | 172.7 | 12 | 33.8** | 54 | 30.3 |
| Urinary Bladder | 11 | 24.6** | 85 | 39.6 | * | # | 17 | 9.2** |
| Kidney and Renal Pelvis | 12 | 26.8** | 52 | 23.6 | * | # | 18 | 8.6** |
| Brain and Other Nervous System | * | # | 25 | 11.0 | * | # | 19 | 8.3** |
| Non-Hodgkin Lymphoma | 10 | 21.5** | 42 | 19.7 | * | # | 17 | 8.4** |
| Myeloma | * | # | 14 | 6.9** | * | # | 14 | 7.5** |
| Leukemia | 11 | 24.9** | 31 | 14.4 | * | # | 17 | 8.6** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 246 | 425.3 | 1,246 | 442.1 | 88 | 144.8 | 545 | 189.1 |
| Colon excluding Rectum | 24 | 39.6 | 122 | 42.1 | 12 | 19.5** | 49 | 16.7 |
| Rectum and Rectosigmoid Junction | 10 | 16.9** | 43 | 14.9 | * | # | 6 | 2.1** |
| Liver | * | # | 7 | 2.4** | * | # | 6 | 2.1** |
| Pancreas | 10 | 17.0** | 32 | 11.2 | 6 | 9.4** | 27 | 9.4 |
| Lung and Bronchus | 39 | 65.2 | 213 | 74.2 | 25 | 41.0 | 169 | 58.7 |
| Melanoma of the Skin | * | # | 35 | 12.8 | * | # | 4 | # |
| Breast | 62 | 108.5 | 363 | 129.6 | 14 | 23.8** | 77 | 26.9 |
| Cervix Uteri | * | # | 32 | 12.0 | * | # | 10 | 3.5** |
| Corpus Uteri | 14 | 25.7** | 51 | 18.0 | * | # | 6 | 2.1** |
| Ovary | 9 | 15.7** | 48 | 16.9 | * | # | 31 | 10.7 |
| Urinary Bladder | 7 | 11.8** | 26 | 9.2 | * | # | 1 | # |
| Kidney and Renal Pelvis | 5 | 9.2** | 28 | 10.1 | * | # | 10 | 3.5** |
| Brain and Other Nervous System | * | # | 13 | 5.0** | * | # | 11 | 4.0** |
| Non-Hodgkin Lymphoma | 7 | 11.6** | 41 | 14.9 | 6 | 9.4** | 20 | 6.8 |
| Myeloma | * | # | 14 | 4.8** | * | # | 11 | 3.9** |
| Leukemia | 5 | 8.7** | 30 | 10.9 | * | # | 27 | 9.5 |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, June 2007
Table of Contents
Table 5-9: Cass
Table 5-11: Clay
